Evaluation of zonulin levels in patients with migraine
Elevated zonulin levels in patients with migraine support the disruption of the intestinal barrier and neuroinflammation in these patients. The zonulin level may be a predictive biomarker of migraine. Multicenter, randomized trials are needed to evaluate treatments for intestinal permeability and zonulin levels in migraine patients.
Authors
- Gözde Ülfer (ORCID: https://orcid.org/0000-0003-2350-6381)
- Ahmet Yabalak (ORCID: https://orcid.org/0000-0002-3317-9567)
- Çağrı Çakici (ORCID: https://orcid.org/0000-0002-8662-5284)
- Burcu Polat (ORCID: https://orcid.org/0000-0002-4104-8508)
Institutions
- Istanbul Medipol University (TR)
- Düzce Üniversitesi (TR)
Publication Details
- Journal
- BMC Neurology
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1186/s12883-025-04058-y
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47